Chromocell Therapeutics Corporation Stock
Equities
CHRO
US1711261057
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.54 USD | +25.71% | -22.95% | 0.00% |
Financials (USD)
Sales 2022 | - | Sales 2023 | - | Capitalization | 7.07M |
---|---|---|---|---|---|
Net income 2022 | -2M | Net income 2023 | -7M | EV / Sales 2022 * | - |
Net cash position 2022 * | - | Net cash position 2023 * | - | EV / Sales 2023 * | - |
P/E ratio 2022 * |
-
| P/E ratio 2023 * |
-
| Employees | 3 |
Yield 2022 * |
-
| Yield 2023 * |
-
| Free-Float | 25.82% |
Latest transcript on Chromocell Therapeutics Corporation
1 day | +25.71% | ||
1 week | -22.95% | ||
Current month | -41.22% | ||
1 month | -49.34% |
1st Jan change | Capi. | |
---|---|---|
0.00% | 7.07M | |
-3.10% | 102B | |
+2.11% | 96.07B | |
-1.80% | 21.66B | |
-17.75% | 20.77B | |
-6.91% | 18.53B | |
-42.00% | 16.91B | |
-28.19% | 13.79B | |
+0.18% | 13.33B | |
+19.90% | 10.94B |
- Stock Market
- Equities
- CHRO Stock